Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Ischemic Cerebral Stroke - Pipeline Review, H1 2013 - New Market Study Published


Print article Print article
2013-07-20 02:26:34 - Fast Market Research recommends "Ischemic Cerebral Stroke - Pipeline Review, H1 2013" from Global Markets Direct, now available

Global Markets Direct's, 'Ischemic Cerebral Stroke - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Ischemic Cerebral Stroke, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ischemic Cerebral Stroke. Ischemic Cerebral Stroke - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of

data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Ischemic Cerebral Stroke.
* A review of the Ischemic Cerebral Stroke products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Ischemic Cerebral Stroke pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/647064_ischemic_cerebral_stroke_pipeline_rev ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Ischemic Cerebral Stroke.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Ischemic Cerebral Stroke pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Report Table of Contents:

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Ischemic Cerebral Stroke Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Ischemic Cerebral Stroke 6
Ischemic Cerebral Stroke Therapeutics under Development by Companies 8
Early Clinical Stage Products 9
Comparative Analysis 9
Pre-Clinical Stage Products 10
Comparative Analysis 10
Ischemic Cerebral Stroke Therapeutics - Products under Development by Companies 11
Companies Involved in Ischemic Cerebral Stroke Therapeutics Development 12
Johnson & Johnson 12
Stempeutics Research Private Limited 13
Ischemic Cerebral Stroke - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
CNTO-0007 - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
NT-KC-005 - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Ischemic Cerebral Stroke Therapeutics - Discontinued Products 21
Ischemic Cerebral Stroke - Product Development Milestones 22
Featured News & Press Releases 22
Oct 08, 2012: NoNO's Drug NA-1 Found To Prevent Stroke Damage 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Number of Products Under Development for Ischemic Cerebral Stroke, H1 2013 6
Products under Development for Ischemic Cerebral Stroke - Comparative Analysis, H1 2013 7
Number of Products under Development by Companies, H1 2013 8
Comparative Analysis by Early Clinical Stage Development, H1 2013 9
Comparative Analysis by Pre-Clinical Stage Development, H1 2013 10
Products under Development by Companies, H1 2013 11
Johnson & Johnson, H1 2013 12
Assessment by Monotherapy Products, H1 2013 14
Assessment by Stage and Route of Administration, H1 2013 16
Assessment by Stage and Molecule Type, H1 2013 18
Ischemic Cerebral Stroke Therapeutics - Discontinued Products 21

List of Figures
Number of Products under Development for Ischemic Cerebral Stroke, H1 2013 6
Products under Development for Ischemic Cerebral Stroke - Comparative Analysis, H1 2013 7
Products under Development by Companies, H1 2013 8
Early Clinical Stage Products, H1 2013 9
Pre-Clinical Stage Products, H1 2013 10
Assessment by Monotherapy Products, H1 2013 14
Assessment by Route of Administration, H1 2013 15
Assessment by Stage and Route of Administration, H1 2013 16
Assessment by Molecule Type, H1 2013 17
Assessment by Stage and Molecule Type, H1 2013 18

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com